19 June 2015
In end-May, Arterium Corporation backed three major medical conventions in a row in Uzbekistan. The 7th Quinquennial Uzbekistan Cardiology Congress on strategic objectives for diminishing morbidity and mortality of cardiovascular disease. Prof. Dr. scient. med. Alexander Ye. Filippov (1st Department of Therapy at S.M. Kirov Military Medical Academy) reported on Arterium Corporation's Thiotriazolin.